North America Opioids Market Size, Share & Trends Analysis Report By Product (IR/Short-acting, ER/Long-acting), By Application (Pain Relief, Anesthesia,Cough Suppression), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Application
                       1.1.3. Regional scope
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. Regional outlook
                   2.3. Competitive Insights
Chapter 3. North America Opioids Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. North America Opioids Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. North America Opioids: Product Estimates & Trend Analysis
                   4.1. North America Opioids Market: Key Takeaways
                   4.2. North America Opioids Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Immediate Release/ Short-acting Opioids
                       4.3.1. Immediate release/ Short acting opioids market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.2. Codeine
                           4.3.2.1. Codeine market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.3. Oxycodone
                           4.3.3.1. Oxycodone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.4. Hydrocodone
                           4.3.4.1. Hydrocodone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.5. Fentanyl
                           4.3.5.1. Fentanyl market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.6. Morphine
                           4.3.6.1. Morphine market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.7. Hydroxymorphone
                           4.3.7.1. Hydroxymorphone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.8. Oxymorphone
                           4.3.8.1. Oxymorphone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.9. Propoxyphene
                           4.3.9.1. Propoxyphene market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.3.10. Others
                           4.3.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Extended Release/Long-acting Opioids
                       4.4.1. Extended release/Long-acting opioids market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.2. Oxycodone
                           4.4.2.1. Oxycodone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.3. Hydrocodone
                           4.4.3.1. Hydrocodone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.4. Methadone
                           4.4.4.1. Methadone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.5. Fentanyl
                           4.4.5.1. Fentanyl market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.6. Morphine
                           4.4.6.1. Morphine market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.7. Oxymorphone
                           4.4.7.1. Oxymorphone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.8. Tapentadol
                           4.4.8.1. Tapentadol market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.9. Buprenorphine
                           4.4.9.1. Buprenorphine market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.10. Hydromorphone
                           4.4.10.1. Hydromorphone market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.11. Others
                           4.4.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. North America Opioids Market: Application Estimates & Trend Analysis
                   5.1. North America Opioids Market: Key Takeaways
                   5.2. North America Opioids Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Pain Relief
                       5.3.1. Pain relief market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.2. Cancer Pain
                           5.3.2.1. Cancer pain market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.3. Post-Operative Care
                           5.3.3.1. Post-operative care market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.4. Lower Back Pain
                           5.3.4.1. Lower back pain market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.5. Orthopedic
                           5.3.5.1. Orthopedic market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.6. Neuropathic
                           5.3.6.1. Neuropathic market estimates and forecasts, 2018 to 2030 (USD Million)
                       5.3.7. Fibromyalgia
                           5.3.7.1. Fibromyalgia market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. Anesthesia
                       5.4.1. Anesthesia market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Cough Suppression
                       5.5.1. Cough suppression market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Diarrhea Suppression
                       5.6.1. Diarrhea suppression market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.7. De-addiction
                       5.7.1. De-addiction market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. North America Opioids Market: Regional Estimates & Trend Analysis
                   6.1. Regional Outlook
                   6.2. North America Opioids Market by Region: Key Marketplace Takeaway
                   6.3. North America
                       6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.2. U.S.
                           6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.3. Canada
                           6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Market Participant Categorization
                       7.2.1. Purdue Pharma L.P.
                           7.2.1.1. Company overview
                           7.2.1.2. Financial performance
                           7.2.1.3. Product benchmarking
                           7.2.1.4. Strategic initiatives
                       7.2.2. Janssen Global Services, LLC
                           7.2.2.1. Company overview
                           7.2.2.2. Financial performance
                           7.2.2.3. Product benchmarking
                           7.2.2.4. Strategic initiatives
                       7.2.3. Hikma Pharmaceuticals PLC
                           7.2.3.1. Company overview
                           7.2.3.2. Financial performance
                           7.2.3.3. Product benchmarking
                           7.2.3.4. Strategic initiatives
                       7.2.4. Pfizer Inc.
                           7.2.4.1. Company overview
                           7.2.4.2. Financial performance
                           7.2.4.3. Product benchmarking
                           7.2.4.4. Strategic initiatives
                       7.2.5. AbbVie Inc.
                           7.2.5.1. Company overview
                           7.2.5.2. Financial performance
                           7.2.5.3. Product benchmarking
                           7.2.5.4. Strategic initiatives
                       7.2.6. Sanofi
                           7.2.6.1. Company overview
                           7.2.6.2. Financial performance
                           7.2.6.3. Product benchmarking
                           7.2.6.4. Strategic initiatives
                       7.2.7. Sun Pharmaceutical Industries Ltd.
                           7.2.7.1. Company overview
                           7.2.7.2. Financial performance
                           7.2.7.3. Product benchmarking
                           7.2.7.4. Strategic initiatives
                       7.2.8. Mallinckrodt Pharmaceuticals
                           7.2.8.1. Company overview
                           7.2.8.2. Financial performance
                           7.2.8.3. Product benchmarking
                           7.2.8.4. Strategic initiatives
                       7.2.9. Endo Pharmaceuticals
                           7.2.9.1. Company overview
                           7.2.9.2. Financial performance
                           7.2.9.3. Product benchmarking
                           7.2.9.4. Strategic initiatives
                       7.2.10. Teva Pharmaceutical Industries
                           7.2.10.1. Company overview
                           7.2.10.2. Financial performance
                           7.2.10.3. Product benchmarking
                           7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America opioids market, by product, 2018 - 2030 (USD Million)
Table 3 North America opioids market, by application, 2018 - 2030 (USD Million)
Table 4 North America opioids market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. opioids market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. opioids market, by application, 2018 - 2030 (USD Million)
Table 7 Canada opioids market, by product, 2018 - 2030 (USD Million)
Table 8 Canada opioids market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Opioids: Market outlook
Fig. 9 Opioids: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 North America opioids market driver impact
Fig. 14 North America opioids market restraint impact
Fig. 15 North America opioids market strategic initiatives analysis
Fig. 16 North America opioids market: Product movement analysis
Fig. 17 North America opioids market: Product outlook and key takeaways
Fig. 18 Immediate release/ Short acting opioids market estimates and forecasts, 2018 - 2030
Fig. 19 Codeine market estimates and forecasts, 2018 - 2030
Fig. 20 Oxycodone market estimates and forecasts, 2018 - 2030
Fig. 21 Hydrocodone market estimates and forecasts, 2018 - 2030
Fig. 22 Fentanyl market estimates and forecasts, 2018 - 2030
Fig. 23 Morphine market estimates and forecasts, 2018 - 2030
Fig. 24 Hydroxymorphone market estimates and forecasts, 2018 - 2030
Fig. 25 Oxymorphone market estimates and forecasts, 2018 - 2030
Fig. 26 Propoxyphene market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 North America opioids market: Application movement analysis
Fig. 29 North America opioids market: Application outlook and key takeaways
Fig. 30 Extended release/Long acting opioids market estimates and forecasts, 2018 - 2030
Fig. 31 Oxycodone market estimates and forecasts, 2018 - 2030
Fig. 32 Hydrocodone market estimates and forecasts, 2018 - 2030
Fig. 33 Methadone market estimates and forecasts, 2018 - 2030
Fig. 34 Fentanyl market estimates and forecasts, 2018 - 2030
Fig. 35 Morphine market estimates and forecasts, 2018 - 2030
Fig. 36 Oxymorphone market estimates and forecasts, 2018 - 2030
Fig. 37 Tapentadol market estimates and forecasts, 2018 - 2030
Fig. 38 Buprenorphine market estimates and forecasts, 2018 - 2030
Fig. 39 Hydromorphone market estimates and forecasts, 2018 - 2030
Fig. 40 Others market estimates and forecasts, 2018 - 2030
Fig. 41 North America opioids market: Regional movement analysis
Fig. 42 North America opioids market: Regional outlook and key takeaways
Fig. 43 North America market estimates and forecasts, 2018 - 2030
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
Fig. 45 Canada market estimates and forecasts, 2018 - 2030